Skip to main content
SpringerLink
Log in
Book cover

Allogeneic Stem Cell Transplantation pp 219–260Cite as

Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

  • Chapter
  • First Online:

  • 1446 Accesses

Part of the book series: Contemporary Hematology ((CH))

Abstract

Acute lymphoblastic leukemia (ALL) is the most common neoplastic disease in childhood with an incidence of four new diagnoses per year out of 100,000 children below 18 years of age [1-3].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Spix C, Eletr D, Blettner M, Kaatsch P (2008) Temporal trends in the incidence rate of childhood cancer in Germany 1987-2004. Int J Cancer 122(8):1859-67

    Article  PubMed  CAS  Google Scholar 

  2. Dalmasso P, Pastore G, Zuccolo L, Maule MM, Pearce N, Merletti F, Magnani C (2005) Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north-west Italy, 1967-2001. A report of the Childhood Cancer Registry of Piedmont. Haematologica 90(9):1197-1204

    PubMed  Google Scholar 

  3. Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 112(2):416-32

    Article  PubMed  Google Scholar 

  4. Pinkel D (1996) Selecting treatment for children with acute lymphoblastic leukemia. J Clin Oncol 14(1):4-6

    PubMed  CAS  Google Scholar 

  5. Pui C-H, Schrappe M, Masera G et al (2004) Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop. Leukemia 18(6):1043-1053

    Article  PubMed  Google Scholar 

  6. Tzortzatou-Stathopoulou F, Papadopoulou AL, Moschovi M et al (2001) Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. J Pediatr Hematol Oncol 23(9):591-597 Review

    Article  PubMed  CAS  Google Scholar 

  7. Schrappe M, Reiter A, Ludwing WD et al (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 95(11):3310-3322

    PubMed  CAS  Google Scholar 

  8. Schrappe M, Reiter A, Zimmermann M et al (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Leukemia 14(12):2205-2222

    Article  PubMed  CAS  Google Scholar 

  9. Borowitz MJ, Devidas M, Hunger SP et al (2008) Children’s Oncology Group. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study. Blood 111(12):5477-5485

    Article  PubMed  CAS  Google Scholar 

  10. Chessells JM (2000) The management of high-risk lymphoblastic leukaemia in children. Br J Haematol 108(2):204-16 Review

    Article  PubMed  CAS  Google Scholar 

  11. Eden OB (1999) Acute lymphoblastic leukaemia: whom and when should we transplant? Pediatr Transplant 3(Suppl 1):108-15

    Article  PubMed  Google Scholar 

  12. Chessells JM, Bailey C, Richards SM (1995) Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet 345(8943):143-8

    Article  PubMed  CAS  Google Scholar 

  13. Eden OB (2000) Therapeutic trials in childhood ALL: what’s their future? J Clin Pathol 53(1):55-9

    Article  PubMed  CAS  Google Scholar 

  14. Davies SM, Ramsay NK, Klein JP et al (2000) Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 18(2):340-7

    PubMed  CAS  Google Scholar 

  15. Borgmann A, Zinn C, Hartmann R et al (2008) Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer 44(2):257-68

    Article  PubMed  Google Scholar 

  16. Metha PA, Davies SM (2008) Allogeneic transplantation for childhood ALL. Bone Marrow Transplant 41(2):133-9

    Article  Google Scholar 

  17. Rocha V, Locatelli F (2008) Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 41(2):207-14

    Article  PubMed  CAS  Google Scholar 

  18. Petersdorf EW (2004) HLA matching in allogeneic stem cell transplantation. Curr Opin Hematol 11(6):386-91 Review

    Article  PubMed  CAS  Google Scholar 

  19. Peters C, Schrauder A, Schrappe M, von Stackelberg A, Stary J, Yaniv I, Gadner H, Klingebiel T, BFM Study Group, the IBFM-Study Group and the Paediatric Disease Working Party of the EBMT (2005) Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts. Bone Marrow Transplant 35(Suppl 1):S9-S11

    Article  Google Scholar 

  20. Smith M, Arthur D, Camitta B et al (1996) Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14(1):18-24

    PubMed  CAS  Google Scholar 

  21. Kosaka Y, Koh K, Kinukawa N et al (2004) Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood 104(12):3527-34

    Article  PubMed  CAS  Google Scholar 

  22. Sallan SE (2006) Myths and lessons from the adult/pediatric interface in acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 128-132. Review

    Google Scholar 

  23. Barry E, DeAngelo DJ, Neuberg D et al (2007) Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol 25(7):813-9

    Article  PubMed  CAS  Google Scholar 

  24. Chessells JM, Harrison CJ, Watson SL et al (2002) Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999. Br J Haematol 117(2):306-14

    Article  PubMed  CAS  Google Scholar 

  25. Isoyama K, Eguchi M, Hibi S et al (2002) Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96). Br J Haematol 118(4):999-1010

    Article  PubMed  CAS  Google Scholar 

  26. Biondi A, Rizzari C, Valsecchi MG et al (2006) Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. Haematologica 91(4):534-7

    PubMed  Google Scholar 

  27. Jansen MW, Corral L, van der Velden VH et al (2007) Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 21(4):633-41

    PubMed  CAS  Google Scholar 

  28. Pieters R, Schrappe M, De Lorenzo P et al (2007) A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 370(9583):240-50

    Article  PubMed  CAS  Google Scholar 

  29. Tauchi H, Tomizawa D, Eguchi M et al (2008) Clinical features and outcome of MLL gene rearranged acute lymphoblastic leukemia in infants with additional chromosomal abnormalities other than 11q23 translocation. Leuk Res 32(10):1523-9

    Article  PubMed  CAS  Google Scholar 

  30. Tomizawa D, Koh K, Sato T et al (2007) Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study G. Leukemia 21(11):2258-63

    Article  PubMed  CAS  Google Scholar 

  31. Aricò M, Ziino O, Valsecchi MG, Cazzaniga G, Baronci C, Messina C, Pession A, Santoro N, Basso G, Conter V, the Italian Association of Pediatric Hematology and Oncology (AIEOP) (2008) Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Cancer 113(3):515-21

    Article  PubMed  Google Scholar 

  32. Whitlock JA, Sather HN, Gaynon P, Robison LL, Wells RJ, Trigg M, Heerema NA, Bhatia S (2005) Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children’s Cancer Group study. Blood 106(13):4043-9

    Article  PubMed  CAS  Google Scholar 

  33. Meissner B, Borkhardt A, Dilloo D et al (2007) Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia. Bone Marrow Transplant 40(10):945-9

    Article  PubMed  CAS  Google Scholar 

  34. Whitlock JA, Sather HN, Gaynon P et al (2005) Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children’s Cancer Group study. Blood 106(13):4043-9

    Article  PubMed  CAS  Google Scholar 

  35. Chessells JM, Harrison G, Richards SM et al (2001) Down’s syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment. Arch Dis Child 85(4):321-5

    Article  PubMed  CAS  Google Scholar 

  36. Schultz KR, Pullen DJ, Sather HN et al (2007) Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG). Blood 109(3):926-35

    Article  PubMed  CAS  Google Scholar 

  37. Mussolin L, Pillon M, Conter V et al (2007) Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood. J Clin Oncol 25(33):5254-61

    Article  PubMed  Google Scholar 

  38. Attias D, Weitzman S (2008) The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Curr Opin Pediatr 20(1):17-22

    Article  PubMed  Google Scholar 

  39. Schrauder A, Reiter A, Gadner H et al (2006) Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. J Clin Oncol 24(36):5742-9

    Article  PubMed  Google Scholar 

  40. Jones LK, Saha V (2005) Philadelphia positive acute lymphoblastic leukaemia of childhood. Br J Haematol 130(4):489-500

    Article  PubMed  Google Scholar 

  41. Aricò M, Valsecchi MG, Camitta B et al (2000) Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 342(14):998-1006

    Article  PubMed  Google Scholar 

  42. Roy A, Bradburn M, Moorman AV et al (2005) Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial. Br J Haematol 129(1):35-44

    Article  PubMed  Google Scholar 

  43. Balduzzi A, Valsecchi MG, Uderzo C et al (2005) Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 366(9486):635-42

    Article  PubMed  Google Scholar 

  44. Talano JM, Casper JT, Camitta BM et al (2006) Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. Bone Marrow Transplant 37(2):135-41

    Article  PubMed  CAS  Google Scholar 

  45. Mann G, Cazzaniga G, van der Velden VH et al (2007) Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The ‘big sister’ of the infant disease? Leukemia 21(4):642-6

    PubMed  CAS  Google Scholar 

  46. Nachman J, Sather HN, Gaynon PS et al (1997) Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children’s Cancer Group. J Clin Oncol 15(6):2222-30

    PubMed  CAS  Google Scholar 

  47. Aricò M, Valsecchi MG, Conter V et al (2002) Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II. Blood 100(2):420-6

    Article  PubMed  Google Scholar 

  48. Coustan-Smith E, Gajjar A, Hijiya N et al (2004) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia 18:499-504

    Article  PubMed  CAS  Google Scholar 

  49. Eckert C, Biondi A, Seeger K et al (2001) Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia. Lancet 358(9289):1239-41

    Article  PubMed  CAS  Google Scholar 

  50. van der Velden VH, Panzer-Grümayer ER, Cazzaniga G et al (2007) Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia 21(4):706-13

    PubMed  Google Scholar 

  51. van der Velden VH, Cazzaniga G, Schrauder A et al (2007) Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 21(4):604-11

    PubMed  Google Scholar 

  52. Flohr T, Schrauder A, Cazzaniga G et al (2008) Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphobl. Leukemia 22(4):771-82

    Article  PubMed  CAS  Google Scholar 

  53. Flotho C, Coustan-Smith E, Pei D et al (2007) A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukaemia. Blood 110:1271-1277

    Article  PubMed  CAS  Google Scholar 

  54. Satwani P, Sather H, Ozkaynak F et al (2007) Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: a Children’s Oncology Group study report. Biol Blood Marrow Transplant 13(2):218-27

    Article  PubMed  CAS  Google Scholar 

  55. Sanders JE, Im HJ, Hoffmeister PA et al (2005) Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood 105(9):3749-56

    Article  PubMed  CAS  Google Scholar 

  56. Chessells JM, Richards SM, Bailey CC et al (1995) Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br J Haematol 89(2):364-72

    Article  PubMed  CAS  Google Scholar 

  57. Silverman LB, Gelber RD, Dalton VK et al (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 97(5):1211-8

    Article  PubMed  CAS  Google Scholar 

  58. Conter V, Aricò M, Valsecchi MG et al (1998) Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Haematologica 83(9):791-9

    PubMed  CAS  Google Scholar 

  59. Gaynon PS, Steinherz PG, Bleyer WA et al (1993) Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106. J Clin Oncol 11(11):2234-42

    PubMed  CAS  Google Scholar 

  60. Schrappe M, Aricò M, Harbott J et al (1998) Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 92(8):2730-4

    PubMed  CAS  Google Scholar 

  61. Uckun FM, Nachman JB, Sather HN et al (1998) Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children’s Cancer Group. Cancer 83(9):2030-9

    Article  PubMed  CAS  Google Scholar 

  62. Nachman JB, Sather HN, Sensel MG et al (1998) Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 338(23):1663-71

    Article  PubMed  CAS  Google Scholar 

  63. Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BE, Kinsey SE, Eden TO, Vora AJ, Mitchell CD, Harrison CJ, UK Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Childhood Leukaemia Working Party (CLWP) (2007) Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood 109(6):2327-30

    Article  PubMed  CAS  Google Scholar 

  64. Saarinen UM, Mellander L, Nysom K et al (1996) Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO). Bone Marrow Transplant 17(3):357-63

    PubMed  CAS  Google Scholar 

  65. Wheeler KA, Richards SM, Bailey CC et al (2000) Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI. Blood 96(7):2412-8

    PubMed  CAS  Google Scholar 

  66. Gray R, Wheatley K (1991) How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant 7(Suppl 3):9-12 Review

    PubMed  Google Scholar 

  67. Ribera JM, Ortega JJ, Oriol A et al (2007) Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial. J Clin Oncol 25(1):16-24

    Article  PubMed  CAS  Google Scholar 

  68. Iori AP, Arcese W, Milano F et al (2007) Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up. Haematologica 92(8):1051-8

    Article  PubMed  Google Scholar 

  69. Locatelli F, Zecca M, Messina C et al (2002) Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia 16(11):2228-37

    Article  PubMed  CAS  Google Scholar 

  70. Bunin N, Carston M, Wall D et al (2002) Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 99(9):3151-7

    Article  PubMed  CAS  Google Scholar 

  71. Dini G, Valsecchi MG, Micalizzi C et al (2003) Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission. Bone Marrow Transplant 32(3):325-31

    Article  PubMed  CAS  Google Scholar 

  72. Tsurusawa M, Yumura-Yagi K, Ohara A et al (2007) Survival outcome after the first central nervous system relapse in children with acute lymphoblastic leukemia: a retrospective analysis of 79 patients in a joint program involving the experience of three Japanese study groups. Int J Hematol 85(1):36-40

    Article  PubMed  Google Scholar 

  73. Bleakley M, Shaw PJ, Nielsen JM (2002) Allogeneic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor. Bone Marrow Transplant 30(1):1-7

    Article  PubMed  CAS  Google Scholar 

  74. Willemze AJ, Geskus RB, Noordijk EM et al (2007) HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI. Bone Marrow Transplant 40(4):319-27

    Article  PubMed  CAS  Google Scholar 

  75. Gassas A, Ishaqi MK, Afzal S et al (2008) Outcome of haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia in third complete remission: a vital role for graft-versus-host-disease/ graft-versus-leukaemia effect in survival. Br J Haematol 140(1):86-9

    PubMed  Google Scholar 

  76. Afify Z, Hunt L, Green A et al (2005) Factors affecting the outcome of stem cell transplantation from unrelated donors for childhood acute lymphoblastic leukemia in third remission. Bone Marrow Transplant 35(11):1041-7

    Article  PubMed  CAS  Google Scholar 

  77. Woolfrey AE, Anasetti C, Storer B et al (2002) Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 99(6):2002-8

    Article  PubMed  CAS  Google Scholar 

  78. Sedláček P, Formanková R, Keslová P et al (2006) Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin. Bone Marrow Transplant 38(11):745-50

    Article  PubMed  CAS  Google Scholar 

  79. Al-Kasim FA, Thornley I, Rolland M et al (2002) Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Br J Haematol 116(2):483-90

    PubMed  CAS  Google Scholar 

  80. Gassas A, Sung L, Saunders EF et al (2007) Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations. Bone Marrow Transplant 40(10):951-5

    Article  PubMed  CAS  Google Scholar 

  81. Eapen M, Rubinstein P, Zhang MJ et al (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369(9577):1947-54

    Article  PubMed  Google Scholar 

  82. Sanders JE, Guthrie KA, Hoffmeister PA et al (2005) Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 105(3):1348-54

    Article  PubMed  CAS  Google Scholar 

  83. Houtenbos I, Bracho F, Davenport V et al (2001) Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC). Bone Marrow Transplant 27(2):145-53

    Article  PubMed  CAS  Google Scholar 

  84. Balduzzi A, Conter V, Uderzo C, Valsecchi MG (2007) Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now? J Clin Oncol 25(18):2625-6

    Article  PubMed  Google Scholar 

  85. Gustafsson Jernberg A, Remberger M, Ringdén O et al (2004) Risk factors in pediatric stem cell transplantation for leukaemia. Pediatr Transplant 8(5):464-74

    Article  PubMed  Google Scholar 

  86. Balduzzi A, De Lorenzo P, Schrauder A, Conter V, Uderzo C, Peters C, Klingebiel T, Stary J, Felice MS, Magyarosy E, Schrappe M, Dini G, Gadner H, Valsecchi MG (2008) Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time. Haematologica 93:925-929

    Article  PubMed  Google Scholar 

  87. Gratwohl A, Baldomero H, Frauendorfer K et al (2007) Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 39(2):71-87

    Article  PubMed  CAS  Google Scholar 

  88. Eapen M, Rubinstein P, Zhang MJ et al (2006) Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 24(1):145-51

    Article  PubMed  Google Scholar 

  89. Quaranta BP, Halperin EC, Kurtzberg J et al (2004) The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation. Cancer 101(4):845-50

    Article  PubMed  Google Scholar 

  90. Malempati S, Gaynon PS, Sather H et al (2007) Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children’s Oncology Group study CCG-1952. J Clin Oncol 25(36):5800-7

    Article  PubMed  Google Scholar 

  91. Lawson SE, Harrison G, Richards S et al (2000) The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. Br J Haematol 108(3):531-43

    Article  PubMed  CAS  Google Scholar 

  92. Chessells JM, Veys P, Kempski H et al (2003) Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 123(3):396-405

    Article  PubMed  Google Scholar 

  93. Rizzari C, Valsecchi MG, Aricò M et al (2004) Outcome of very late relapse in children with acute lymphoblastic leukemia. Haematologica 89(4):427-34

    PubMed  Google Scholar 

  94. Roy A, Cargill A, Love S et al (2005) Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial. Br J Haematol 130(1):67-75

    Article  PubMed  Google Scholar 

  95. Einsiedel HG, von Stackelberg A, Hartmann R et al (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87. J Clin Oncol 23(31):7942-50

    Article  PubMed  Google Scholar 

  96. Eapen M, Zhang MJ, Devidas M et al (2008) Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children’s Oncology Group and the Center for International Blood and Marrow Transplant Research. Leukemia 22(2):281-6

    Article  PubMed  CAS  Google Scholar 

  97. Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM (2006) Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children’s Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 107(12):4961-7

    Article  PubMed  CAS  Google Scholar 

  98. Gaynon PS, Harris RE, Altman AJ et al (2006) Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children’s Oncology Group study CCG. J Clin Oncol 24(19):3150-6

    Article  PubMed  Google Scholar 

  99. Dopfer R, Henze G, Bender-Götze C et al (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood 78(10):2780-4

    PubMed  CAS  Google Scholar 

  100. Borgmann A, von Stackelberg A, Hartmann R et al (2003) Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood 101(10):3835-9

    Article  PubMed  CAS  Google Scholar 

  101. Harrison G, Richards S, Lawson S et al (2000) Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party. Ann Oncol 11(8):999-1006

    Article  PubMed  CAS  Google Scholar 

  102. von Stackelberg A, Hartmann R, Bührer C et al (2008) High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia. Blood 111(5):2573-80

    Article  CAS  Google Scholar 

  103. Wheeler K, Richards S, Bailey C, Chessells J (1998) Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia. Br J Haematol 101(1):94-103

    Article  PubMed  CAS  Google Scholar 

  104. Bader P, Hancock J, Kreyenberg H (2002) Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia 16(9):1668-72

    Article  PubMed  CAS  Google Scholar 

  105. Goulden N, Bader P, Van Der Velden V et al (2003) Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia. Br J Haematol 122(1):24-9

    Article  PubMed  Google Scholar 

  106. Knechtli CJ, Goulden NJ, Hancock JP et al (1998) Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood 92(11):4072-9

    PubMed  CAS  Google Scholar 

  107. Krejci O, van der Velden VH, Bader P et al (2003) Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group. Bone Marrow Transplant 32(8):849-51

    Article  PubMed  CAS  Google Scholar 

  108. Dufourg MN, Landman-Parker J, Auclerc MF et al (2007) Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children. Leukemia 21(2):238-47

    Article  PubMed  CAS  Google Scholar 

  109. Jansen NC, Kingma A, Schuitema A et al (2006) Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: a prospective, sibling-controlled study. Eur J Cancer 42(16):2765-72

    Article  PubMed  Google Scholar 

  110. Krappmann P, Paulides M, Stöhr W et al (2007) Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up. Pediatr Hematol Oncol 24(2):101-9

    Article  PubMed  CAS  Google Scholar 

  111. Waber DP, Turek J, Catania L et al (2007) Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol 25(31):4914-21

    Article  PubMed  CAS  Google Scholar 

  112. Matsuzaki A, Nagatoshi Y, Inada H et al (2005) Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation - a report from the Kyushu-Yamaguchi Children’s Cancer Study Group. Pediatr Blood Cancer 45(2):111-20

    Article  PubMed  Google Scholar 

  113. Borgmann A, Baumgarten E, Schmid H et al (1997) Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative? Bone Marrow Transplant 20(11):939-44

    Article  PubMed  CAS  Google Scholar 

  114. Blair A, Goulden NJ, Libri NA et al (2005) Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation. Blood Rev 19(6):289-300

    Article  PubMed  CAS  Google Scholar 

  115. Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringdén O, Wagner JE (2004) Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 22(24):4872-80

    Article  PubMed  Google Scholar 

  116. Marks DI, Khattry N, Cummins M et al (2006) Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 134(2):196-201

    Article  PubMed  Google Scholar 

  117. Ishaqi MK, Afzal S, Dupuis A et al (2008) Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia. Bone Marrow Transplant 41(3):245-52

    Article  PubMed  CAS  Google Scholar 

  118. Rocha V, Michel G, Kabbara N, et al (2005) Outcomes after unrelated cord blood transplantation in children with acute lymphoblastic leukemia. An Eurocord-Netcord survey. Blood abstract# 304, page 93a.

    Google Scholar 

  119. Rocha V, Cornish J, Sievers E, Filipovich A, Locatelli F, Peters C et al (2001) Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97:2962-2971

    Article  PubMed  CAS  Google Scholar 

  120. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE (2001) Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97:2957-2961

    Article  PubMed  CAS  Google Scholar 

  121. Dalle JH, Duval M, Moghrabi A, Wagner JE, Vachon MF, Barrette S et al (2004) Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 33:605-11

    Article  PubMed  CAS  Google Scholar 

  122. Hwang WY, Samuel M, Tan D, Koh LP, Lim W, Linn YC (2007) A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant 13:444-53

    Article  PubMed  Google Scholar 

  123. Rocha V, Gluckman E (2007) Outcomes of transplantation in children with acute leukaemia. Lancet 369(9577):1906-8

    Article  PubMed  Google Scholar 

  124. Hough R, Labopin M, Michel G, Locatelli F, Klingebiel T, Arcese W et al (2007) Outcomes of fully haplo-identical haematopoietic stem cell transplantation compared to unrelated cord blood transplantation in children with acute lymphoblastic leukaemia. A retrospective analysis on behalf of Eurocord, PDWP and ALWP of EBMT. Bone Marrow Transplant 39(S1):S3

    Google Scholar 

  125. Bunin N, Aplenc R, Kamani N et al (2003) Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transplant 32(6):543-8

    Article  PubMed  CAS  Google Scholar 

  126. Jamieson CH, Amylon MD, Wong RM et al (2003) Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience. Exp Hematol 31(10):981-6

    Article  PubMed  Google Scholar 

  127. Marks DI, Forman SJ, Blume KG et al (2006) A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant 12(4):438-53

    Article  PubMed  CAS  Google Scholar 

  128. Ringdén O, Ruutu T, Remberger M et al (1994) A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 83(9):2723-30

    PubMed  Google Scholar 

  129. Zecca M, Pession A, Messina C, Bonetti F, Favre C, Prete A, Cesaro S, Porta F, Mazzarino I, Georgiani G, Rondelli R, Locatelli F (1999) Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings. J Clin Oncol 17(6):1838-1846

    PubMed  CAS  Google Scholar 

  130. Iravani M, Evazi MR, Mousavi SA et al (2007) Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients. Bone Marrow Transplant 40(2):105-10

    Article  PubMed  CAS  Google Scholar 

  131. Brydøy M, Fosså SD, Dahl O et al (2007) Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol 46(4):480-9

    Article  PubMed  Google Scholar 

  132. Chow EJ, Friedman DL, Yasui Y et al (2007) Decreased adult height in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Pediatr 150(4):370-5 375

    Article  PubMed  Google Scholar 

  133. Cohen IJ (2007) Comparison of long-term neurocognitive outcomes in young children with acute lymphatic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 25(6):734-5

    Article  PubMed  Google Scholar 

  134. Löf CM, Forinder U, Winiarski J (2007) Risk factors for lower health-related QoL after allogeneic stem cell transplantation in children. Pediatr Transplant 11(2):145-51

    Article  PubMed  Google Scholar 

  135. Bader P, Niethammer D, Willasch A et al (2005) How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 35(2):107-19

    Article  PubMed  CAS  Google Scholar 

  136. Sànchez J, Serrano J, Gòmez P et al (2002) Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation. Br J Haematol 116(3):686-94

    Article  PubMed  Google Scholar 

  137. Uzunel M, Jaksch M, Mattsson J et al (2003) Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia. Br J Haematol 122(5):788-94

    Article  PubMed  Google Scholar 

  138. Uzunel M, Mattsson J, Jakssch M et al (2001) The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia. Blood 98(6):1982-4

    Article  PubMed  CAS  Google Scholar 

  139. Gadner H, Masera G, Schrappe M et al (2006) The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop (‘Ponte di legno meeting’) report: Vienna, Austria, April 27-28, 2005. Leukemia 20(1):9-17

    Article  PubMed  CAS  Google Scholar 

  140. Aricò M, Baruchel A, Bertrand Y et al (2005) The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop report: Palermo, Italy, January 29-30, 2005. Leukemia 19(7):1145-52

    Article  PubMed  Google Scholar 

  141. Saarinen-Pihkala UM, Heilmann C, Winiarski J et al (2006) Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data. J Clin Oncol 24(36):5750-62

    Article  PubMed  Google Scholar 

  142. Rivera GK, Zhou Y, Hancock ML et al (2005) Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia. Cancer 103(2):368-76

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematopoeitic Transplant Unit, Clinica Pediatrica, Università degli Studi di Milano, Bicocca Ospedale, San Gerardo, Italy

    Adriana Balduzzi & Lucia Di Maio

  2. Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA

    Mary Eapen

  3. Acute Leukemia Working Party of the European Blood and Marrow Transplant Group, Hopital Saint Antoine and Hematopoeitic Transplant Unit and Eurocord Registry, Hopital Saint Louis, Assistance Publique des Hopitaux de Paris, University of Paris, Paris, France

    Vanderson Rocha

Authors
  1. Adriana Balduzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucia Di Maio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary Eapen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vanderson Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University Hospitals Case Medical Center, Cleveland, OH, USA

    Hillard M. Lazarus

  2. Case Western Reserve University, Cleveland, OH, USA

    Mary J. Laughlin

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Balduzzi, A., Di Maio, L., Eapen, M., Rocha, V. (2010). Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia. In: Lazarus, H.M., Laughlin, M.J. (eds) Allogeneic Stem Cell Transplantation. Contemporary Hematology. Humana Press. https://doi.org/10.1007/978-1-59745-478-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-478-0_15

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-33-6

  • Online ISBN: 978-1-59745-478-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation